Bioscience firm to create 70 jobs in Prince William
Virongy Biosciences will invest $471,000 in expansion
Manassas-based Virongy Biosciences Inc. will invest $471,000 to expand in Prince William County, creating 70 jobs, Gov. Glenn Youngkin announced Tuesday.
The company relocated within Prince William County in February, moving from a roughly 600-square-foot space to about 2,000 square feet in the Northern Virginia Bioscience Center. It plans to develop diagnostic technologies to monitor and quantify COVID-19 variants and other viral pathogens.
“Prince William County has emerged as a hub for the life sciences industry, offering the infrastructure, R&D assets and talent to attract and retain innovative biotech firms like Virongy,” Youngkin said in a statement. “We applaud the company for its groundbreaking developments that will have a positive and far-reaching impact on bioscience advancements and disease prevention and treatment.”
Established in 2014, Virongy develops viral diagnostic technologies, anti-viral drugs and therapeutic viral vectors. The company develops technologies for scientific discoveries, clinical diagnostics and disease treatment. Virongy has developed rapid quantitative COVID-19 antibody tests and HIV drug and antibody discovery technologies.
“Virongy Biosciences Inc. chose Virginia as its company location mainly because it is inside the rapid-growing biotech park of Prince William County, and right beside the Science and Technology Campus of George Mason University,” Virongy Chief Scientific Officer Brian Hetrick said.
The Virginia Economic Development Partnership worked with Prince William County to secure the project for Virginia, and VEDP’s Virginia Jobs Investment Program will provide funding to support employee recruitment and training activities.